Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
21.83
-0.82 (-3.62%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Pulse Biosciences Revenue
In the year 2025, Pulse Biosciences had annual revenue of $350.00K. Pulse Biosciences had revenue of $264.00K in the quarter ending December 31, 2025.
Revenue (ttm)
$350.00K
Revenue Growth
n/a
P/S Ratio
4,240.58
Revenue / Employee
$3,017
Employees
116
Market Cap
1.48B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| ICU Medical | 2.23B |
| Warby Parker | 871.91M |
| Azenta | 595.03M |
| AtriCure | 534.53M |
| LeMaitre Vascular | 249.60M |
| STAAR Surgical Company | 239.44M |
| BioLife Solutions | 96.21M |
PLSE News
- 3 days ago - Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026 - Business Wire
- 8 days ago - Pulse Biosciences' nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Business Wire
- 11 days ago - Pulse Biosciences to Host Analyst Event on April 25, 2026 - Business Wire
- 12 days ago - Pulse Biosciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Pulse Biosciences Strengthens Executive Leadership Team - Business Wire
- 21 days ago - Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation - Business Wire
- 26 days ago - Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 5 weeks ago - Pulse Biosciences Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference - Transcripts